Treatment of Gastritis
The recommended first-line treatment for gastritis is H. pylori eradication therapy for patients with confirmed H. pylori infection, and proton pump inhibitor (PPI) therapy for non-H. pylori gastritis. 1
Diagnostic Approach
- Patients >45 years with severe symptoms or any patients with alarm symptoms (anemia, weight loss, dysphagia, palpable mass, malabsorption) should be referred for endoscopy before treatment 1
- Younger patients (<45 years) without alarm symptoms can be managed in primary care with H. pylori testing and eradication 1
Treatment Algorithm
For H. pylori-Associated Gastritis:
First-line regimen (standard triple therapy):
- PPI (e.g., omeprazole 20mg) twice daily
- Amoxicillin 1g twice daily
- Clarithromycin 500mg twice daily
- Duration: 14 days (superior to 7-day regimens by ~5%) 1
For penicillin allergy (bismuth quadruple therapy):
- PPI twice daily
- Bismuth 300mg four times daily
- Tetracycline 500mg four times daily
- Metronidazole 500mg three times daily
- Duration: 14 days 1
If first-line treatment fails:
- Consider levofloxacin-based regimen:
- PPI twice daily
- Bismuth 300mg four times daily
- Levofloxacin 500mg once daily
- Tetracycline 500mg four times daily
- Duration: 14 days 1
- Consider levofloxacin-based regimen:
For Non-H. pylori Gastritis:
- PPI therapy:
Follow-up and Confirmation of Eradication
- Confirm H. pylori eradication at least 4 weeks after completion of treatment 1
- Use urea breath test (UBT) or laboratory-based validated monoclonal stool antigen test 1
- Ensure patient has been off PPI for at least 2 weeks before testing 1
Maintenance Therapy
- For uncomplicated duodenal ulcer: No prolonged PPI therapy needed after successful H. pylori eradication 1
- For complicated duodenal ulcer: Continue PPI until H. pylori eradication is confirmed 1
- For erosive esophagitis: Long-term PPI maintenance therapy may be indicated 1, 2
Important Clinical Considerations
PPI Dosing
- High-dose PPI increases the efficacy of triple therapy by 6-10% compared to standard doses 1
- Standard PPI doses:
- Omeprazole 20mg
- Lansoprazole 30mg
- Pantoprazole 40mg
- Esomeprazole 20mg
- Rabeprazole 20mg
- Dexlansoprazole 30mg 1
Regional Considerations
- In areas with high clarithromycin resistance (>15-20%), avoid clarithromycin-based regimens 1
Special Populations
- For patients with renal impairment:
- GFR 10-30 mL/min: Adjust amoxicillin to 500mg or 250mg every 12 hours
- GFR <10 mL/min: Adjust to 500mg or 250mg every 24 hours 1
- For patients with bleeding ulcers: Start treatment when oral feeding is resumed 1
Patient Education
- Inform patients about potential side effects:
- Darkening of stool (from bismuth)
- Metallic taste
- Nausea and diarrhea
- Skin rash
- Muscle and joint pains 1
- Emphasize the importance of completing the full course of treatment 1
- Taking medications with meals improves tolerance and efficacy 1
Pitfalls to Avoid
- Not confirming H. pylori eradication: Always confirm eradication at least 4 weeks after treatment completion 1
- Inadequate treatment duration: 14-day regimens are superior to 7-day regimens 1
- Not adjusting therapy for antibiotic resistance: In areas with high clarithromycin resistance, avoid clarithromycin-based regimens 1
- Premature PPI discontinuation: Continue PPI until complete healing for gastric ulcers 1
- Testing for H. pylori eradication while on PPI: Ensure patient has been off PPI for at least 2 weeks before testing 1